InsiderTrades.com logo

TRDA Insider Trading

Insider Ownership Percentage: 8.11%
Insider Buying (Last 12 Months): $1,352,567.90
Insider Selling (Last 12 Months): $5,898,990.58

Entrada Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Entrada Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Entrada Therapeutics Share Price & Price History

Current Price: $12.31
Price Change: ▲ Price Increase of +0.26 (2.16%)
As of 03/26/2026 05:00 PM ET

This chart shows the closing price history over time for TRDA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Entrada Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/10/2026Kory James WentworthCFOSell11,388$13.02$148,271.76121,510View SEC Filing Icon  
3/10/2026Nathan J. DowdenCOOSell11,894$13.05$155,216.70198,588View SEC Filing Icon  
3/9/2026Kory James WentworthCFOSell5,089$13.00$66,157.00132,898View SEC Filing Icon  
3/9/2026Nathan J. DowdenCOOSell3,116$13.02$40,570.32210,482View SEC Filing Icon  
3/4/2026Kory James WentworthCFOSell7,988$12.25$97,853.00137,987View SEC Filing Icon  
11/21/2025Kory James WentworthCFOSell8,910$9.98$88,921.80110,026View SEC Filing Icon  
11/14/2025Kush ParmarDirectorSell200,000$8.80$1,760,000.002,963,066View SEC Filing Icon  
11/14/2025Ventures V L.P. 5AmMajor ShareholderSell200,000$8.80$1,760,000.002,963,066View SEC Filing Icon  
11/12/2025Bros. Advisors Lp BakerMajor ShareholderBuy100,736$7.76$781,711.364,664,924View SEC Filing Icon  
11/11/2025Bros. Advisors Lp BakerMajor ShareholderBuy46,434$7.50$348,255.004,572,549View SEC Filing Icon  
11/10/2025Bros. Advisors Lp BakerMajor ShareholderBuy30,874$7.21$222,601.544,529,969View SEC Filing Icon  
7/9/2025Kush ParmarDirectorSell27,000$7.50$202,500.001,093,313View SEC Filing Icon  
7/9/2025Ventures V L.P. 5AmMajor ShareholderSell20,065$7.50$150,487.503,163,066View SEC Filing Icon  
7/9/2025Ventures V L.P. 5AmMajor ShareholderSell6,935$7.50$52,012.501,093,313View SEC Filing Icon  
6/30/2025Kush ParmarDirectorSell25,000$6.81$170,250.001,106,670View SEC Filing Icon  
6/30/2025Ventures V L.P. 5AmMajor ShareholderSell18,578$6.81$126,516.183,201,709View SEC Filing Icon  
6/30/2025Ventures V L.P. 5AmMajor ShareholderSell6,422$6.81$43,733.821,106,670View SEC Filing Icon  
6/27/2025Kush ParmarDirectorSell75,000$6.91$518,250.001,113,092View SEC Filing Icon  
6/27/2025Ventures V L.P. 5AmMajor ShareholderSell55,735$6.91$385,128.853,220,287View SEC Filing Icon  
6/27/2025Ventures V L.P. 5AmMajor ShareholderSell19,265$6.91$133,121.151,113,092View SEC Filing Icon  
12/10/2024Bioventures 2018 L.P. MpmMajor ShareholderSell22,935$20.77$476,359.954,402,849View SEC Filing Icon  
12/2/2024Kory James WentworthCFOSell5,000$20.00$100,000.0073,849View SEC Filing Icon  
11/29/2024Kory James WentworthCFOSell1,000$19.97$19,970.0073,849View SEC Filing Icon  
11/13/2024Natarajan SethuramanInsiderSell2,700$20.04$54,108.00160,888View SEC Filing Icon  
11/11/2024Kory James WentworthCFOSell8,637$19.98$172,567.2673,849View SEC Filing Icon  
11/11/2024Natarajan SethuramanInsiderSell1,409$20.01$28,194.09163,588View SEC Filing Icon  
10/16/2024Natarajan SethuramanInsiderSell600$18.00$10,800.00183,216View SEC Filing Icon  
9/26/2024Nathan J. DowdenCOOSell847$16.00$13,552.00125,149View SEC Filing Icon  
9/9/2024Kory James WentworthCFOSell3,195$14.97$47,829.1576,486View SEC Filing Icon  
9/9/2024Natarajan SethuramanInsiderSell2,642$15.09$39,867.78183,816View SEC Filing Icon  
9/9/2024Nathan J. DowdenCOOSell1,904$15.07$28,693.28125,996View SEC Filing Icon  
9/6/2024Natarajan SethuramanInsiderSell600$15.24$9,144.00186,458View SEC Filing Icon  
9/6/2024Nathan J. DowdenCOOSell399$15.19$6,060.81127,900View SEC Filing Icon  
7/15/2024Dipal DoshiCEOSell1,600$17.81$28,496.00334,475View SEC Filing Icon  
7/15/2024Natarajan SethuramanInsiderSell638$18.00$11,484.00188,814View SEC Filing Icon  
7/12/2024Dipal DoshiCEOSell300$18.00$5,400.00336,075View SEC Filing Icon  
7/12/2024Natarajan SethuramanInsiderSell600$18.00$10,800.00189,452View SEC Filing Icon  
7/8/2024Kory James WentworthCFOSell1,758$14.95$26,282.1081,412View SEC Filing Icon  
6/13/2024Dipal DoshiCEOSell1,000$16.17$16,170.00336,375View SEC Filing Icon  
5/20/2024Natarajan SethuramanInsiderSell9,675$15.19$146,963.25190,052View SEC Filing Icon  
5/16/2024Dipal DoshiCEOSell1,800$15.00$27,000.00338,575View SEC Filing Icon  
5/16/2024Natarajan SethuramanInsiderSell1,000$15.00$15,000.00208,032View SEC Filing Icon  
5/8/2024Peter S KimDirectorBuy2,276$14.04$31,955.0465,212View SEC Filing Icon  
4/8/2024Peter S KimDirectorBuy2,600$13.57$35,282.0062,936View SEC Filing Icon  
3/28/2024Peter S KimDirectorBuy1,512$13.75$20,790.0060,336View SEC Filing Icon  
3/25/2024Peter S KimDirectorBuy3,180$13.36$42,484.8056,074View SEC Filing Icon  
3/21/2024Peter S KimDirectorBuy704$13.24$9,320.9649,776View SEC Filing Icon  
3/19/2024Peter S KimDirectorBuy900$12.66$11,394.0047,944View SEC Filing Icon  
2/15/2024Dipal DoshiCEOSell1,000$15.00$15,000.00243,279View SEC Filing Icon  
1/16/2024Dipal DoshiCEOSell1,000$15.99$15,990.00244,279View SEC Filing Icon  
12/26/2023Kory James WentworthCFOSell94$16.67$1,566.9849,571View SEC Filing Icon  
12/22/2023Kory James WentworthCFOSell10,206$15.69$160,132.1449,571View SEC Filing Icon  
12/20/2023Dipal DoshiCEOSell1,000$15.00$15,000.00245,279View SEC Filing Icon  
11/13/2023Dipal DoshiCEOSell1,000$16.23$16,230.00246,279View SEC Filing Icon  
10/17/2023Dipal DoshiCEOSell1,000$15.00$15,000.00247,279View SEC Filing Icon  
9/13/2023Dipal DoshiCEOSell1,000$15.00$15,000.00248,279View SEC Filing Icon  
9/6/2023Kory James WentworthCFOSell950$13.48$12,806.0049,571View SEC Filing Icon  
9/6/2023Nathan J. DowdenCOOSell972$13.47$13,092.8448,168View SEC Filing Icon  
9/6/2023Nerissa KreherInsiderSell892$13.48$12,024.1640,037View SEC Filing Icon  
8/14/2023Dipal DoshiCEOSell1,000$15.67$15,670.00201,069View SEC Filing Icon  
8/4/2023Nerissa KreherInsiderSell6,898$14.14$97,537.7227,130View SEC Filing Icon  
8/2/2023Nerissa KreherInsiderSell10,348$15.19$157,186.1227,130View SEC Filing Icon  
7/11/2023Kory James WentworthCFOSell3,884$18.00$69,912.0036,747View SEC Filing Icon  
7/10/2023Natarajan SethuramanInsiderSell3,026$18.00$54,468.00168,299View SEC Filing Icon  
7/10/2023Nathan J. DowdenCOOSell3,200$18.00$57,600.0039,273View SEC Filing Icon  
6/22/2023Nathan J. DowdenCOOSell7,097$16.02$113,693.9442,473View SEC Filing Icon  
6/21/2023Kory James WentworthCFOSell17,500$15.01$262,675.0027,957View SEC Filing Icon  
6/20/2023Nathan J. DowdenCOOSell8,885$14.94$132,741.9049,570View SEC Filing Icon  
4/27/2023Dipal DoshiCEOSell2,000$13.71$27,420.00202,069View SEC Filing Icon  
4/17/2023Dipal DoshiCEOSell2,092$18.01$37,676.92204,069View SEC Filing Icon  
4/17/2023Natarajan SethuramanInsiderSell3,961$18.00$71,298.00171,325View SEC Filing Icon  
3/27/2023Dipal DoshiCEOSell2,000$14.72$29,440.00255,811View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Entrada Therapeutics (NASDAQ:TRDA)

86.39% of Entrada Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TRDA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Entrada Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/19/2026Invesco Ltd.41,033$0.42M0.0%+41.1%0.107%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd117,668$1.21M0.0%+26.4%0.308%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP1,044,758$10.74M0.0%+9.5%2.734%Search for SEC Filing on Google Icon
2/18/2026Sphera Funds Management LTD.110,942$1.14M0.2%N/A0.290%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd20,318$0.21M0.0%+13.5%0.053%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC497,695$5.12M0.0%-40.5%1.302%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.14,017$0.14M0.0%N/A0.037%Search for SEC Filing on Google Icon
2/18/2026Baker BROS. Advisors LP5,072,730$52.15M0.3%+4.3%13.272%Search for SEC Filing on Google Icon
2/18/20265AM Venture Management LLC4,056,379$41.70M13.1%-4.7%10.613%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC26,254$0.27M0.0%+87.6%0.069%Search for SEC Filing on Google Icon
2/17/2026Cantor Fitzgerald L. P.57,000$0.59M0.0%-15.3%0.149%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP121,280$1.25M0.0%-1.3%0.317%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD327,423$3.37M0.0%-9.2%0.857%Search for SEC Filing on Google Icon
2/17/2026Public Employees Retirement System of Ohio37,502$0.39M0.0%+33.0%0.098%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.11,571$0.12M0.0%+31.4%0.030%Search for SEC Filing on Google Icon
2/17/2026ExodusPoint Capital Management LP37,430$0.39M0.0%N/A0.098%Search for SEC Filing on Google Icon
2/17/2026Magnetar Financial LLC13,373$0.14M0.0%N/A0.035%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC67,147$0.69M0.0%+10.7%0.176%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP20,657$0.21M0.0%N/A0.054%Search for SEC Filing on Google Icon
2/13/2026Walleye Capital LLC13,534$0.14M0.0%-86.0%0.035%Search for SEC Filing on Google Icon
2/13/2026Jacobs Levy Equity Management Inc.362,786$3.73M0.0%+14.9%0.949%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.221,269$2.28M0.0%+19.4%0.579%Search for SEC Filing on Google Icon
2/13/2026State Street Corp508,789$5.23M0.0%+2.0%1.331%Search for SEC Filing on Google Icon
2/13/2026Dynamic Technology Lab Private Ltd25,302$0.26M0.1%N/A0.066%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN32,163$0.33M0.0%+48.8%0.084%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC17,802$0.18M0.0%+148.6%0.047%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC252,635$2.60M0.0%-57.5%0.661%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP273,378$2.81M0.0%-30.7%0.715%Search for SEC Filing on Google Icon
2/12/2026Great Lakes Advisors LLC43,268$0.45M0.0%+5.5%0.113%Search for SEC Filing on Google Icon
2/11/2026Los Angeles Capital Management LLC45,952$0.47M0.0%-11.8%0.120%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.205,173$2.11M0.0%-7.7%0.537%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC11,929$0.12M0.0%-13.8%0.031%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC639,947$6.58M0.0%-0.8%1.674%Search for SEC Filing on Google Icon
2/9/2026Royce & Associates LP247,147$2.54M0.0%-28.5%0.647%Search for SEC Filing on Google Icon
1/15/2026Allspring Global Investments Holdings LLC17,495$0.18M0.0%+9.8%0.046%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.133,878$0.78M0.0%+735.0%0.350%Search for SEC Filing on Google Icon
12/1/2025Cantor Fitzgerald L. P.67,334$0.39M0.0%N/A0.176%Search for SEC Filing on Google Icon
11/17/2025Jacobs Levy Equity Management Inc.315,810$1.83M0.0%+43.1%0.826%Search for SEC Filing on Google Icon
11/17/2025NewEdge Advisors LLC14,167$82K0.0%N/A0.037%Search for SEC Filing on Google Icon
11/17/2025XTX Topco Ltd93,079$0.54M0.0%N/A0.244%Search for SEC Filing on Google Icon
11/17/2025Sherbrooke Park Advisers LLC18,573$0.11M0.1%N/A0.049%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd287,873$1.67M0.0%+115.3%0.753%Search for SEC Filing on Google Icon
11/17/2025Prelude Capital Management LLC25,754$0.15M0.0%N/A0.067%Search for SEC Filing on Google Icon
11/17/2025Public Employees Retirement System of Ohio28,202$0.16M0.0%+88.0%0.074%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC836,609$4.85M0.0%+391.2%2.189%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.13,108$76K0.0%-14.8%0.034%Search for SEC Filing on Google Icon
11/17/2025Jain Global LLC11,954$69K0.0%N/A0.031%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC335,741$1.95M0.0%+234.5%0.878%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE126,448$0.73M0.0%+246.7%0.331%Search for SEC Filing on Google Icon
11/17/2025Cantor Fitzgerald L. P.67,334$0.39M0.0%N/A0.176%Search for SEC Filing on Google Icon
11/17/2025Algert Global LLC129,812$0.75M0.0%N/A0.340%Search for SEC Filing on Google Icon
11/17/2025Alliancebernstein L.P.24,320$0.14M0.0%+7.1%0.064%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.69,926$0.41M0.0%+55.6%0.183%Search for SEC Filing on Google Icon
11/14/2025Occudo Quantitative Strategies LP29,486$0.17M0.0%+190.6%0.077%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP93,194$0.54M0.0%N/A0.244%Search for SEC Filing on Google Icon
11/14/2025Bridgeway Capital Management LLC40,000$0.23M0.0%N/A0.105%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets148,212$0.86M0.0%+4,767.4%0.388%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.8,808$51K0.0%+72.7%0.023%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP394,279$2.29M0.0%-7.0%1.032%Search for SEC Filing on Google Icon
11/12/2025Royce & Associates LP345,507$2M0.0%+54.8%0.904%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC13,843$80K0.0%-21.8%0.036%Search for SEC Filing on Google Icon
11/10/2025TD Asset Management Inc37,788$0.22M0.0%-20.9%0.099%Search for SEC Filing on Google Icon
11/10/2025AXQ Capital LP11,570$67K0.0%N/A0.030%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP55,960$0.33M0.0%N/A0.147%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.133,878$0.78M0.0%+735.0%0.352%Search for SEC Filing on Google Icon
11/3/2025AlphaQuest LLC6,475$38K0.0%-83.7%0.017%Search for SEC Filing on Google Icon
11/3/2025Great Lakes Advisors LLC41,029$0.24M0.0%N/A0.108%Search for SEC Filing on Google Icon
10/29/2025Inscription Capital LLC11,835$69K0.0%N/A0.031%Search for SEC Filing on Google Icon
8/19/2025State of Wyoming7,575$51K0.0%+130.9%0.020%Search for SEC Filing on Google Icon
8/15/2025Man Group plc16,805$0.11M0.0%N/A0.044%Search for SEC Filing on Google Icon
8/15/2025IHT Wealth Management LLC10,700$72K0.0%N/A0.028%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE36,473$0.25M0.0%+35.6%0.096%Search for SEC Filing on Google Icon
8/15/20255AM Venture Management LLC4,308,379$28.95M11.1%-2.3%11.326%Search for SEC Filing on Google Icon
8/15/2025Ameriprise Financial Inc.44,946$0.30M0.0%+9.6%0.118%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC51,158$0.34M0.0%N/A0.134%Search for SEC Filing on Google Icon
8/14/2025Occudo Quantitative Strategies LP10,148$68K0.0%N/A0.027%Search for SEC Filing on Google Icon
8/14/2025Qube Research & Technologies Ltd133,730$0.90M0.0%+435.1%0.352%Search for SEC Filing on Google Icon
8/14/2025Federated Hermes Inc.96,686$0.65M0.0%-2.1%0.254%Search for SEC Filing on Google Icon
8/13/2025Walleye Capital LLC17,409$0.12M0.0%N/A0.046%Search for SEC Filing on Google Icon
8/13/2025First Trust Advisors LP75,120$0.51M0.0%+3.6%0.197%Search for SEC Filing on Google Icon
8/13/2025Invesco Ltd.22,393$0.15M0.0%+34.2%0.059%Search for SEC Filing on Google Icon
8/13/2025Arrowstreet Capital Limited Partnership102,008$0.69M0.0%-17.7%0.268%Search for SEC Filing on Google Icon
8/13/2025Virtus Investment Advisers LLC11,979$80K0.0%+32.1%0.031%Search for SEC Filing on Google Icon
8/12/2025Prudential Financial Inc.28,340$0.19M0.0%+23.4%0.075%Search for SEC Filing on Google Icon
8/12/2025American Century Companies Inc.75,094$0.51M0.0%+10.8%0.197%Search for SEC Filing on Google Icon
8/12/2025Rhumbline Advisers39,095$0.26M0.0%+8.3%0.103%Search for SEC Filing on Google Icon
8/12/2025Dynamic Technology Lab Private Ltd24,734$0.17M0.0%N/A0.065%Search for SEC Filing on Google Icon
8/8/2025Intech Investment Management LLC17,702$0.12M0.0%+15.7%0.047%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC631,554$4.25M0.0%+7.2%1.664%Search for SEC Filing on Google Icon
8/7/2025Los Angeles Capital Management LLC44,632$0.30M0.0%+60.6%0.118%Search for SEC Filing on Google Icon
8/5/2025Corton Capital Inc.28,755$0.19M0.2%N/A0.076%Search for SEC Filing on Google Icon
7/31/2025AlphaQuest LLC39,625$0.27M0.0%+239.8%0.104%Search for SEC Filing on Google Icon
7/9/2025Harbor Capital Advisors Inc.15,277$0.10M0.0%+14.0%0.040%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.92,540$0.84M0.0%-67.6%0.244%Search for SEC Filing on Google Icon
5/28/2025Strs Ohio41,800$0.38M0.0%N/A0.110%Search for SEC Filing on Google Icon
5/21/2025Acadian Asset Management LLC21,141$0.19M0.0%-58.9%0.056%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.92,540$0.84M0.0%-67.6%0.244%Search for SEC Filing on Google Icon
5/16/2025Jacobs Levy Equity Management Inc.210,873$1.91M0.0%-0.9%0.556%Search for SEC Filing on Google Icon
5/16/2025AQR Capital Management LLC30,919$0.28M0.0%-43.8%0.081%Search for SEC Filing on Google Icon
5/15/2025State of Wyoming3,280$30K0.0%-45.7%0.009%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Entrada Therapeutics logo
Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its EEV platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. Its therapeutic candidates, which include ENTR-601-44, which is in Phase I clinical trial for the treatment of Duchenne muscular dystrophy; and ENTR-701, which is in Phase 1/2 clinical trial for the treatment of myotonic dystrophy type 1. The company also offers ENTR-601-45 and ENTR-601-50, which are in preclinical trail for the treatment of Duchenne muscular dystrophy; and ENTR-501, an intracellular thymidine phosphorylase enzyme replacement therapy, which is in preclinical trail for the treatment of mitochondrial neurogastrointestinal encephalomyopathy. Entrada Therapeutics, Inc. has a strategic collaboration and license agreement with Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize ENTR-701. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Read More on Entrada Therapeutics

Today's Range

Now: $12.31
Low: $11.84
High: $12.52

50 Day Range

MA: $11.62
Low: $10.07
High: $13.50

52 Week Range

Now: $12.31
Low: $4.93
High: $13.65

Volume

138,477 shs

Average Volume

240,890 shs

Market Capitalization

$471.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Entrada Therapeutics?

Entrada Therapeutics' top insider shareholders include:
  1. Bros Advisors Lp Baker (Major Shareholder)
  2. Bioventures 2018 LP Mpm (Major Shareholder)
  3. Ventures V LP 5Am (Major Shareholder)
  4. Kush Parmar (Director)
  5. Dipal Doshi (CEO)
  6. Nathan J Dowden (COO)
  7. Natarajan Sethuraman (Insider)
  8. Kory James Wentworth (CFO)
  9. Peter S Kim (Director)
  10. Nerissa Kreher (Insider)
Learn More about top insider investors at Entrada Therapeutics.

Who are the major institutional investors of Entrada Therapeutics?

Entrada Therapeutics' top institutional shareholders include:
  1. Baker BROS. Advisors LP — 13.27%
  2. 5AM Venture Management LLC — 10.61%
  3. Wellington Management Group LLP — 2.73%
  4. Geode Capital Management LLC — 1.67%
  5. State Street Corp — 1.33%
  6. Millennium Management LLC — 1.30%
Learn More about top institutional investors of Entrada Therapeutics stock.

Which institutional investors are selling Entrada Therapeutics stock?

Within the last quarter, TRDA stock was sold by these institutional investors:
  1. Renaissance Technologies LLC
  2. Millennium Management LLC
  3. 5AM Venture Management LLC
  4. Dimensional Fund Advisors LP
  5. Royce & Associates LP
  6. Walleye Capital LLC
  7. Price T Rowe Associates Inc. MD
  8. Goldman Sachs Group Inc.
Within the last year, company insiders that have sold Entrada Therapeutics company stock include:
  1. Bros Advisors Lp Baker (Major Shareholder)
  2. Bioventures 2018 LP Mpm (Major Shareholder)
  3. Ventures V LP 5Am (Major Shareholder)
  4. Kush Parmar (Director)
Learn More investors selling Entrada Therapeutics stock.

Which institutional investors are buying Entrada Therapeutics stock?

In the previous quarter, TRDA stock was bought by institutional investors including:
  1. Baker BROS. Advisors LP
  2. Sphera Funds Management LTD.
  3. Wellington Management Group LLP
  4. Jacobs Levy Equity Management Inc.
  5. ExodusPoint Capital Management LP
  6. Charles Schwab Investment Management Inc.
  7. Dynamic Technology Lab Private Ltd
  8. XTX Topco Ltd
Within the previous year, these company insiders have bought Entrada Therapeutics stock:
  1. Bros Advisors Lp Baker (Major Shareholder)
  2. Bioventures 2018 LP Mpm (Major Shareholder)
Learn More investors buying Entrada Therapeutics stock.

Entrada Therapeutics Active Insiders

Dipal Doshi
Dipal Doshi (Age 50)
CEO
Nathan J Dowden
Nathan J Dowden
President and Chief Operating Officer
2 recent trades
Kory James Wentworth
Kory James Wentworth (Age 47)
CFO
4 recent trades
John F Crowley
John F Crowley
Director
Kush Parmar
Kush Parmar
Director
1 recent trades
Natarajan Sethuraman
Natarajan Sethuraman (Age 64)
Insider